Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Clin Cosmet Investig Dermatol
2015 Aug 17;8:449-54. doi: 10.2147/CCID.S83248.
Show Gene links
Show Anatomy links
Study of lipid profile in adult women with acne.
da Cunha MG
,
Batista AL
,
Macedo MS
,
Machado Filho CD
,
Fonseca FL
.
???displayArticle.abstract???
OBJECTIVE: The aim of this study was to establish the lipid profile of female patients with acne in the Acne-in-Adult-Women Ambulatory Care Clinic in order to observe the prevalence of dyslipidemia in those patients.
METHODS: This is a retrospective transversal study that evaluated the medical records of 416 patients who attended at the Acne-in-Adult-Women Ambulatory Care Clinic, at the Dermatology Department, Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil, in the year 2012. Relevant data included age and clinical classification of acne. The lipid profile was analyzed according to the results of laboratory tests ordered during outpatient visits, which included total and fractionated cholesterol levels and triglycerides.
RESULTS: The epidemiological study sample was of 219 patients, with ages ranging from 21 to 61 years (mean of 32.23 years). The predominant clinical grade was papule-pustule acne (grade II) with 156 patients (71%). Regarding the lipid profile of the patients, there was a high increase in total cholesterol levels in 17.35% of the cases. High-density lipoprotein levels were low in 11.42% of the patients, with normal prevalence in 194 subjects. Low-density lipoprotein levels were normal in most patients (60.27%). Very-low-density lipoprotein values were normal in almost all patients (94.06%) and increased in only 13 patients (5.94%). Only 18 patients presented high levels of triglycerides (8.22%).
CONCLUSION: The conclusion was that patients with grades II and III acne are more likely to have total cholesterol and low-density lipoprotein altered. A correct and early diagnosis can be an important measure for the prevention of the metabolic syndrome in these patients.
Arora,
The relationship of lipid profile and menstrual cycle with acne vulgaris.
2010, Pubmed
Arora,
The relationship of lipid profile and menstrual cycle with acne vulgaris.
2010,
Pubmed
Azziz,
Androgen excess in women: experience with over 1000 consecutive patients.
2004,
Pubmed
Colonna,
Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
2012,
Pubmed
Diamanti-Kandarakis,
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
2010,
Pubmed
Diamanti-Kandarakis,
Pathophysiology and types of dyslipidemia in PCOS.
2007,
Pubmed
El-Mazny,
Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome.
2010,
Pubmed
Fauser,
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
2012,
Pubmed
George,
Hormonal therapy for acne.
2008,
Pubmed
Halperin,
The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.
2011,
Pubmed
Kaminer,
The many faces of acne.
1995,
Pubmed
Koo,
The psychosocial impact of acne: patients' perceptions.
1995,
Pubmed
Kurokawa,
New developments in our understanding of acne pathogenesis and treatment.
2009,
Pubmed
Moura,
Polycystic ovary syndrome: a dermatologic approach.
2011,
Pubmed
Palomba,
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
2009,
Pubmed
Perkins,
Acne vulgaris in women: prevalence across the life span.
2012,
Pubmed
Rachoń,
Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
2010,
Pubmed
Rager,
Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN.
2006,
Pubmed
Repaci,
The role of low-grade inflammation in the polycystic ovary syndrome.
2011,
Pubmed
Shaw,
Acne: effect of hormones on pathogenesis and management.
2002,
Pubmed
Strauss,
Guidelines of care for acne vulgaris management.
2007,
Pubmed
Westerveld,
Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
2008,
Pubmed
Zouboulis,
What is the pathogenesis of acne?
2005,
Pubmed
da Cunha,
Androgenic hormone profile of adult women with acne.
2013,
Pubmed
